IL135911A0 - Dna 19355 polypeptide, a tumor necrosis factor homolog - Google Patents
Dna 19355 polypeptide, a tumor necrosis factor homologInfo
- Publication number
- IL135911A0 IL135911A0 IL13591198A IL13591198A IL135911A0 IL 135911 A0 IL135911 A0 IL 135911A0 IL 13591198 A IL13591198 A IL 13591198A IL 13591198 A IL13591198 A IL 13591198A IL 135911 A0 IL135911 A0 IL 135911A0
- Authority
- IL
- Israel
- Prior art keywords
- polypeptide
- necrosis factor
- tumor necrosis
- dna19355
- dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6563597P | 1997-11-18 | 1997-11-18 | |
US6966197P | 1997-12-12 | 1997-12-12 | |
PCT/US1998/024621 WO1999025834A1 (fr) | 1997-11-18 | 1998-11-18 | Polypeptide adn19355, homologue du facteur de necrose des tumeurs |
Publications (1)
Publication Number | Publication Date |
---|---|
IL135911A0 true IL135911A0 (en) | 2001-05-20 |
Family
ID=26745805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL13591198A IL135911A0 (en) | 1997-11-18 | 1998-11-18 | Dna 19355 polypeptide, a tumor necrosis factor homolog |
Country Status (12)
Country | Link |
---|---|
US (4) | US20020146389A1 (fr) |
EP (1) | EP1032672B1 (fr) |
JP (2) | JP4485049B2 (fr) |
AT (1) | ATE419357T1 (fr) |
AU (1) | AU760010B2 (fr) |
CA (1) | CA2308365A1 (fr) |
DE (1) | DE69840413D1 (fr) |
DK (1) | DK1032672T3 (fr) |
ES (1) | ES2320285T3 (fr) |
IL (1) | IL135911A0 (fr) |
PT (1) | PT1032672E (fr) |
WO (1) | WO1999025834A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6406867B1 (en) | 1996-08-16 | 2002-06-18 | Human Genome Sciences, Inc. | Antibody to human endokine alpha and methods of use |
WO2001040464A1 (fr) * | 1999-11-30 | 2001-06-07 | Genentech, Inc. | Kinase 3 associee au recepteur de l'interleukine 1 (irak3) et son utilisation pour stimuler ou inhiber l'angiogenese et la cardiovascularisation |
ES2307515T3 (es) * | 1999-06-02 | 2008-12-01 | Genentech Inc | Activacion o inhibicion de la angiogenesis y la cardiovascularizacion. |
WO2001003720A2 (fr) * | 1999-07-12 | 2001-01-18 | Genentech, Inc. | Stimulation ou inhibition de l'angiogenese et de la cardiovascularisation avec des homologues de ligands et de recepteurs du facteur de necrose tumorale |
AU6391000A (en) * | 1999-07-28 | 2001-02-19 | Genentech Inc. | Method of preventing the injury or death of retinal cells and treating ocular diseases |
DE10045591A1 (de) * | 2000-09-15 | 2002-04-04 | Klaus Pfizenmaier | Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) |
WO2003006058A1 (fr) * | 2001-07-12 | 2003-01-23 | Wyeth | Marqueurs differentiels cd25+ et leurs utilisations |
AU2002366433A1 (en) * | 2001-08-16 | 2003-09-09 | Human Genome Sciences, Inc. | Methods and compositions for treating metabolic bone diseases relating to human endokine alpha |
CN1658863A (zh) * | 2002-04-08 | 2005-08-24 | 武田药品工业株式会社 | 重症脓毒病预防治疗药物 |
WO2004107618A2 (fr) * | 2003-05-23 | 2004-12-09 | Wyeth | Ligand du gitr et molecules et anticorps lies au ligand du gitr et leurs utilisations |
EP1660126A1 (fr) * | 2003-07-11 | 2006-05-31 | Schering Corporation | Agonistes ou antagonistes du recepteur du facteur de necrose tumorale induit par les glucocorticoides (gitr) ou de son ligand utilises dans le traitement des troubles immuns, des infections et du cancer |
EP1692318A4 (fr) * | 2003-12-02 | 2008-04-02 | Genzyme Corp | Compositions et methodes pour le diagnostic et le traitement du cancer du poumon |
US20070065889A1 (en) * | 2004-12-02 | 2007-03-22 | Roberts Bruce L | Compositions and methods to diagnose and treat lung cancer |
TW201605896A (zh) | 2013-08-30 | 2016-02-16 | 安美基股份有限公司 | Gitr抗原結合蛋白 |
BR112016028378A2 (pt) | 2014-06-06 | 2017-10-24 | Bristol Myers Squibb Co | anticorpos contra o receptor do fator de necrose tumoral induzido por glicocorticoide (gitr) e usos dos mesmos |
MA41460A (fr) | 2015-02-03 | 2017-12-12 | Oncomed Pharm Inc | Agents de liaison à la tnfrsf et leurs utilisations |
WO2016196792A1 (fr) | 2015-06-03 | 2016-12-08 | Bristol-Myers Squibb Company | Anticorps anti-gitr pour le diagnostic du cancer |
AU2016356780A1 (en) | 2015-11-19 | 2018-06-28 | Bristol-Myers Squibb Company | Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof |
AU2017278193B9 (en) | 2016-06-10 | 2024-02-01 | Regeneron Pharmaceuticals, Inc. | Anti-GITR antibodies and uses thereof |
KR20200006115A (ko) | 2017-05-16 | 2020-01-17 | 브리스톨-마이어스 스큅 컴퍼니 | 항-gitr 효능제 항체에 의한 암의 치료 |
US11787867B2 (en) | 2020-03-06 | 2023-10-17 | Regeneron Pharmaceuticals, Inc. | Anti-GITR antibodies and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5288852A (en) * | 1984-03-06 | 1994-02-22 | Dainippon Pharmaceutical Co., Ltd. | Human tumor necrosis factor polypeptides |
KR100510234B1 (ko) * | 1995-06-29 | 2005-11-25 | 임뮤넥스 코포레이션 | 세포소멸을 유도하는 시토킨 |
ATE412740T1 (de) * | 1996-08-16 | 2008-11-15 | Human Genome Sciences Inc | Menschliches alpha-endokin |
US6406867B1 (en) * | 1996-08-16 | 2002-06-18 | Human Genome Sciences, Inc. | Antibody to human endokine alpha and methods of use |
US5998171A (en) * | 1996-08-16 | 1999-12-07 | Human Genome Sciences, Inc. | Polynucleotides encoding human endokine alpha |
-
1998
- 1998-11-18 DK DK98958067T patent/DK1032672T3/da active
- 1998-11-18 DE DE69840413T patent/DE69840413D1/de not_active Expired - Lifetime
- 1998-11-18 WO PCT/US1998/024621 patent/WO1999025834A1/fr active IP Right Grant
- 1998-11-18 CA CA002308365A patent/CA2308365A1/fr not_active Abandoned
- 1998-11-18 AT AT98958067T patent/ATE419357T1/de active
- 1998-11-18 IL IL13591198A patent/IL135911A0/xx unknown
- 1998-11-18 AU AU14180/99A patent/AU760010B2/en not_active Expired
- 1998-11-18 PT PT98958067T patent/PT1032672E/pt unknown
- 1998-11-18 EP EP98958067A patent/EP1032672B1/fr not_active Expired - Lifetime
- 1998-11-18 ES ES98958067T patent/ES2320285T3/es not_active Expired - Lifetime
- 1998-11-18 JP JP2000521199A patent/JP4485049B2/ja not_active Expired - Lifetime
-
2002
- 2002-02-22 US US10/080,455 patent/US20020146389A1/en not_active Abandoned
-
2003
- 2003-11-14 US US10/713,391 patent/US20040234498A1/en not_active Abandoned
-
2005
- 2005-05-06 US US11/123,992 patent/US20070072263A1/en not_active Abandoned
-
2006
- 2006-02-14 US US11/353,441 patent/US20060216270A1/en not_active Abandoned
-
2009
- 2009-12-11 JP JP2009281737A patent/JP2010088448A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
AU760010B2 (en) | 2003-05-08 |
US20040234498A1 (en) | 2004-11-25 |
US20070072263A1 (en) | 2007-03-29 |
PT1032672E (pt) | 2009-04-02 |
DK1032672T3 (da) | 2009-04-27 |
DE69840413D1 (de) | 2009-02-12 |
US20060216270A1 (en) | 2006-09-28 |
CA2308365A1 (fr) | 1999-05-27 |
JP4485049B2 (ja) | 2010-06-16 |
JP2010088448A (ja) | 2010-04-22 |
EP1032672B1 (fr) | 2008-12-31 |
WO1999025834A1 (fr) | 1999-05-27 |
AU1418099A (en) | 1999-06-07 |
JP2001523459A (ja) | 2001-11-27 |
EP1032672A1 (fr) | 2000-09-06 |
ATE419357T1 (de) | 2009-01-15 |
ES2320285T3 (es) | 2009-05-20 |
US20020146389A1 (en) | 2002-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL135911A0 (en) | Dna 19355 polypeptide, a tumor necrosis factor homolog | |
IL193919A0 (en) | DcR3 POLYPEPTIDE A TNFR HOMOLOG | |
TW428026B (en) | Bifunctional protein, preparation and use | |
MX9603532A (es) | Sistema de suministro de acido nucleico, metodo de sintesis y sus usos. | |
NZ504548A (en) | Polypeptides and nucleic acids encoding human chordin | |
DE69930955D1 (de) | Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren | |
DE69535719D1 (de) | Fas-antigenbindender ligand | |
HK1034287A1 (en) | Recombinational cloning using nucleic acids havingrecombination sites | |
DE69532532T8 (de) | Chimerische papillomavirus-ahnliche partikel | |
IE812224L (en) | Interferon | |
IL125168A0 (en) | Apo - 2 ligand | |
EP0237966A3 (fr) | Facteur humain basique de croissance de fibroblaste | |
WO1998021343A8 (fr) | Genes codant des proteines de telomerase | |
DE69837475D1 (de) | Polypeptide mit aminopeptidaseaktivität und dafür kodierende nukleinsäuren | |
IL135051A0 (en) | Apo-3 ligand polypeptide | |
DE59712771D1 (de) | Nebenhoden-spezifisches Rezeptorprotein und dessen Verwendung | |
EP0336383A3 (fr) | Lymphotoxine recombinante humaine | |
ATE236983T1 (de) | Durch zelldichte stimulierte protein-tyrosin- phosphatasen | |
ZA95968B (en) | Interferon alpha/beta binding protein its preparation and use | |
DE69828902D1 (de) | Polypeptide mit 5-aminolevulinsäure synthaseaktivität und deren nukleinsäuren | |
PT1241179E (pt) | Proteína humana possuindo actividade antiproliferativa in vitro | |
MX9802005A (es) | Moleculas de adn circular con origen de replicacion condicional, su proceso de preparacion y su utilizacion en terapia genica. | |
WO2002006340A3 (fr) | Proteine tetraspan et ses utilisations | |
EP2033970A3 (fr) | Gènes inductibles WNT-1 |